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Cellular/Molecular
Neurofascin 140 Is an Embryonic Neuronal Neurofascin
Isoform That Promotes the Assembly of the Node of Ranvier
Ao Zhang,1 Anne Desmazieres,1 Barbara Zonta,1 ShonaMelrose,1 Graham Campbell,1DonMahad,1 Qiushi Li,1
Diane L. Sherman,1 Richard Reynolds,2* and Peter J. Brophy1*
1Centre for Neuroregeneration, The Medical School, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom, and 2Centre for Neuroinflammation
and Neurodegeneration, Faculty of Medicine, Imperial College London, LondonW12 0NN, United Kingdom
Rapid nerve conduction in myelinated nerves requires the clustering of voltage-gated sodium channels at nodes of Ranvier. The Neuro-
fascin (Nfasc) gene has a unique role in node formation because it encodes glial and neuronal isoforms of neurofascin (Nfasc155 and
Nfasc186, respectively) with key functions in assembling the nodal macromolecular complex. A third neurofascin, Nfasc140, has also
been described; however, neither the cellular origin nor function of this isoform was known. Here we show that Nfasc140 is a neuronal
protein strongly expressed duringmouse embryonic development. Expression of Nfasc140 persists but declines during the initial stages
of node formation, in contrast toNfasc155 andNfasc186,which increase. Nevertheless, Nfasc140, likeNfasc186, can cluster voltage-gated
sodium channels (Nav) at the developing node of Ranvier and can restore electrophysiological function independently of Nfasc155 and
Nfasc186. This suggests that Nfasc140 complements the function of Nfasc155 and Nfasc186 in initial stages of the assembly and stabili-
zation of the nodal complex. Further, Nfasc140 is reexpressed in demyelinated white matter lesions of postmortem brain tissue from
human subjects with multiple sclerosis. This expands the critical role of the Nfasc gene in the function of myelinated axons and reveals
further redundancy in the mechanisms required for the formation of this crucial structure in the vertebrate nervous system.
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Introduction
Myelinated nerves can conduct nerve impulses rapidly because
voltage-gated sodium channels are concentrated at the nodes of
Ranvier between successive myelinated segments. Nodes are the
sites of action potential propagation due to the assembly of a
macromolecular complex, including voltage-gated sodium chan-
nels. Components of the nodal complex include IV-spectrin,
ankyrinG, contactin (in the CNS), NrCAMand gliomedin (in the
PNS), and a neuronal isoform of neurofascin, Nfasc186 (Davis et
al., 1996; Berghs et al., 2000; Tait et al., 2000; Jenkins and Bennett,
2002; Yang et al., 2004; Eshed et al., 2005; Bekku and Oohashi,
2010). Flanking the nodes in both the CNS and PNS are the
paranodal axoglial junctions where the terminal loops of the my-
elin sheath physically interact with the axon (Sherman and Bro-
phy, 2005; Salzer et al., 2008). Axon–glial interaction at the
paranode is mediated by an adhesion complex between the glial
isoform of neurofascin, Nfasc155, and the axonal proteins caspr
(also known as paranodin) and contactin (Einheber et al., 1997;
Menegoz et al., 1997; Tait et al., 2000; Bhat et al., 2001; Boyle et al.,
2001; Kazarinova-Noyes et al., 2001; Charles et al., 2002; Sher-
man et al., 2005).
The Neurofascin (Nfasc) gene is essential for the assembly of
the nodal complex (Sherman et al., 2005).Nfasc has a unique role
by encoding a glial isoform, neurofascin 155 (Nfasc155) and a
neuronal isoform, neurofascin 186 (Nfasc186) (Davis and Ben-
nett, 1993, 1994; Davis et al., 1993, 1996; Collinson et al., 1998;
Tait et al., 2000), both of which have key roles in clustering so-
dium channels (Sherman et al., 2005; Zonta et al., 2008; Feinberg
et al., 2010; Thaxton et al., 2011). A third isoform was also de-
scribed in the original discovery of these proteins by Bennett and
colleagues (Davis et al., 1993). This protein has an apparent size
by SDS-PAGE of 140 kDa and was consequently named neuro-
fascin 140 (Nfasc140).Nevertheless, little progress has beenmade
in determining the function of Nfasc140.
Given the complementary roles of glial Nfasc155 and neuro-
nal Nfasc186 in the assembly of nodal complexes, we wished to
determine whether Nfasc140might have a related function. First,
we determined that Nfasc140 is a neuronal protein. We then
investigated whether Nfasc 140 was reexpressed in demyelinated
axons in multiple sclerosis (MS) lesions. To address its function,
we used a transgenic rescue approach, as described previously
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(Sherman et al., 2005). Nfasc140 is as capable as neuronal
Nfasc186 of clustering sodium channels and other members of
the nodal complex at nodes of Ranvier in both the PNS and the
CNS. Hence, we have identified a third member of the neurofas-
cin family with a complementary role to Nfasc155 and Nfasc186
in the assembly of the node of Ranvier. The fact that transgenic
Nfasc140 is also targeted to the axon initial segment (AIS) and
rescues the normal localization of NrCAM also supports the view
that Nfasc140 and Nfasc186 have related functions in stabilizing
this domain (Zonta et al., 2011).
Materials andMethods
Isolation of Nfasc140 cDNA and detection of Nfasc186, Nfasc155, and
Nfasc140 isoforms by RT-PCR. RNA was extracted from mouse hind
brain at E15 and subjected to RT-PCR as described previously (Tait et al.,
2000) using 5-ATGGCCAGGCAGCAGGCGCCAC-3 and 5-CCAT
CTATTCCCTTGCCTGA-3 forward and reverse primers, respectively,
which span the full coding regions of all neurofascins. The gel-purified
product of 3.2 kb was sequenced. To detect Nfasc186, Nfasc155, and
Nfasc140 mRNAs in P21 hind brain or optic nerve, RNA primers span-
ning the second and fourth FNIII repeats common to all three isoforms
were used (5-CGCTACATTGTCAAGTGGCG-3 and 5AAGCGGT
AACGGGACACGGG-3 forward and reverse primers, respectively). The
predicted sizes for Nfasc186 or Nfasc140 mRNAwere 411 bp and 732 bp
for Nfasc155.
Animals.All animal work conformed toUK legislation (Scientific Pro-
cedures) Act 1986, and to the University of Edinburgh Ethical Review
Committee policy. Thy1Nfasc186 transgenic mice expressing full-length
Nfasc186 with a FLAG tag at its C terminus under the control of the
Thy1.2 promoter have been described and are here abbreviated as T186
(Zonta et al., 2011). The Nfasc140 cDNA with a FLAG tag at its C termi-
nus was cloned into the XhoI site of the pTSC21k vector (Lu¨thi et al.,
1997), released by digestion with NotI and transgenic mice expressing
Nfasc140 under the control of the Thy1.2 promoter (T140) were similarly
generated by pronuclear injection. The tamoxifen-inducible Thy1CreERT2
andPLPCreERT2 lines and the floxedNeurofascin line (Nfascfl/fl) have been
described (Leone et al., 2003; Zonta et al., 2011). Induction of recombi-
nation using tamoxifen has been described (Zonta et al., 2011). All lines
were back-crossed to at least F6 to a C57BL/6 background. To express
transgenic Nfasc140 and Nfasc186 on a neurofascin-null background,
the T140 and T186 lines were interbred with Nfasc/mice to generate
T140/Nfasc/ and T186/Nfasc/mice.
Antibodies, microscopy, Western blots, yeast two-hybrid, electrophysiol-
ogy, and behavioral analysis. Immunostaining of teased quadriceps, spi-
nal cord ventral funiculus nerves, and cerebellar sectionswas as described
previously (Sherman et al., 2005; Zonta et al., 2011). Most antibodies
used to stain these preparations have been described (Zonta et al., 2008,
2011) with the addition of anti-GFAP (GA-5, dilution 1:100, Sigma)
and anti-IBA1 (dilution 1:1000, Wako). Samples were mounted in
Vectashield (Vector Laboratories). For confocal microscopy, we used a
Leica TCL-SL confocal microscope and 63 objective, numerical aper-
ture 1.4, and Leica proprietary software. Conventional fluorescence mi-
croscopy was performed using an Olympus BX60 microscope and 40
objective lens, numerical aperture 0.75, and images were captured using
a Hamamatsu Orca-ER camera and Improvision Openlab software. All
figures were prepared using Adobe Photoshop version 7.0 and were not
subjected to any subsequent image processing. Western blotting was
performed as described previously (Sherman et al., 2005). Yeast two-
hybrid interactions were tested exactly as previously described (Sherman
et al., 2001; Gunn-Moore et al., 2006). Electrophysiological measure-
ments of nerve conduction velocity were performed on acutely isolated
quadriceps nerves and performance on rotarod as described previously
(Court et al., 2004; Sherman et al., 2012). All quantitative measurements
were from an equal number of males and females.
MSpostmortem tissues.All postmortem tissues were obtained from the
UK Multiple Sclerosis Society Tissue Bank at Imperial College. The tis-
sues were all collected via a prospective donor scheme following fully
informed consent (08/MRE09/31). The demographic data and clinical
and neuropathological features of the secondary progressive MS cases
and controls are shown in Table 1. The clinical diagnosis of MS was
confirmed based on the patient history and a detailed neuropathological
analysis, as described previously (Reynolds et al., 2011).MSwhitematter
lesions were classified according to the UK MS Society Tissue Bank’s
published criteria (Reynolds et al., 2011) and tissue blocks chosen con-
taining chronic active lesions. The presence of chronic active lesions was
confirmed in serial sections as described previously (Mahad et al., 2009).
Briefly, snap frozen tissue blocks and cryostat sections, cut to a thickness
of 15 m, were kept at80°C for storage. Sections were air dried for an
hour before being fixed in a cold solution of 4% PFA. Antigen retrieval
using 10mM EDTA, pH 8, was performed, and a blocking solution of 1%
normal goat serum was applied. Primary antibodies HLA-DP, DQ, DR
(dilution 1:200, Dako), PLP (dilution 1:500, AbD Serotec), and total
neurofilament (dilution 1:1000, Thermo Scientific) were applied at room
temperature for 90 min. Biotinylated secondary antibodies were added
for 30 min and visualized using DAB. Sections were immersed in a he-
matoxylin solution for 1 min followed by mounting. The borders of the
lesions were scored on the snap frozen tissue block with a scalpel blade,
which allowed separation of the lesion and normal-appearing whitemat-
ter when cryosectioning at 50 m, and 50–150 mg tissue isolated for
subsequent Western blotting.
Results
Nfasc140 is an embryonic neurofascin isoform in neurons
Western blotting of lysates from mouse hindbrains at different
ages showed that a neurofascin band at 140 kDa was expressed in
the embryonic mouse hind brain, whereas Nfasc186, although
also present, became more abundant at the onset of myelination
when Nfasc140 was downregulated (Fig. 1A). The identity of the
band that has an apparent size larger than Nfasc155 between
Nfasc140 and Nfasc186 at E15 is unknown. Nfasc155 expression
is associated with the initiation of myelination (Collinson et al.,
1998), and thiswas reflected in its increased abundance at P8 (Fig.
1A). Because the band with a mobility of 140 kDa was very abun-
dant at E15, we purified hindbrain RNA at E15 and performed
RT-PCR to isolate full-length cDNA clones of Nfasc140. These
clones were sequenced, and the deduced protein domain struc-
ture was compared with the two well-characterized neurofascin
isoforms (Fig. 1B). This confirmed that Nfasc140 lacked the mu-
cin and FNIII5 domains characteristic of neuronal Nfasc186, and
the FNIII3 domain unique to Nfasc155 as found previously by
Bennett and coworkers (Davis et al., 1993) (Fig. 1B).Western blot
analysis confirmed that Nfasc140 lacked the mucin and FNIII5
domains and the FNIII3 domain unique to Nfasc155 (Fig. 1C).
The lower proteins recognized by the extracellular domain-
specific antibodies, NFF3 and MNF2, but not by NFC (which
recognizes the identical intracellular C terminus present in neu-
rofascins 140, 155, and 186), is likely to represent forms of these
proteins that have been subject to extracellular cleavage (Maier et
al., 2006). To determine whether Nfasc140 was expressed by neu-
Table 1. Details of MS and control subjects used in this studya
Case no. Sex Age (yr) PMD (h) Disease duration (yr) Cause of death Course
CO32 M 88 22 — Prostate cancer —
CO36 M 68 30 — Fibrosing alveolitis —
CO37 M 84 5 — Bladder cancer —
CO45 M 77 22 — Pneumonia —
MS200 F 43 20 19 Urinary tract infection SP
MS203 F 53 17 27 Multiple sclerosis SP
MS207 F 46 10 25 Pneumonia SP
MS230 F 42 31 19 Multiple sclerosis SP
MS256 F 53 21 24 Pneumonia SP
MS527 M 47 10 25 Pneumonia SP
aPMD, Postmortem delay; SP, secondary progressive MS.
Zhang et al. • Neuronal Neurofascin Nfasc140 Clusters Nodal Nav J. Neurosci., February 4, 2015 • 35(5):2246–2254 • 2247
rons or myelin-forming glia, we conditionally inactivated theNfasc
gene in either neurons or oligodendrocytes by tamoxifen-inducible
Cre-mediated recombination using mice carrying a floxed allele of
Nfasc and either neuronal-specific (Thy1CreERT2) or glial-
specific (PLPCreERT2) Cre lines. Loss of Nfasc186 using the
neuron-specific Cre together with the considerable depletion of
Nfasc140 suggested that the latter was primarily neuronal in or-
igin (Fig. 1D). This view was supported by the fact that only
Nfasc155 was completely depleted by the glial-specific Cre (Fig.
1D). The persistence of some Nfasc140 after neuron-specific ab-
lationmay reflect the fact thatNfasc140 has a longer half-life than
Nfasc186 (Zonta et al., 2011).
Further evidence thatNfasc140 is a neuronal not a glial protein is
shown in Figure 1 E, F. Sections from mouse cerebellum were
double-labeled with the pan anti-neurofascin antibody (Pan-Nfasc,
NFC) that recognizesNfasc186,Nfasc155, andNfasc140 and either
anti-GFAP (for astrocytes) or IBA1 (for microglia). This shows
staining of axonal nodes and paranodes as expected but no neu-
rofascin staining in either astrocytes or microglia. (Fig. 1E). To
confirm thatNfasc186was not expressed by oligodendrocytes, we
double stained with the Nfasc186-specific MNF2 antibody and
anti-APC (for oligodendrocytes) showing Nfasc186 staining in
axonal nodes as expected (Tait et al., 2000), but no staining in
oligodendrocytes. Hence, Nfasc186 is not expressed in oligoden-
drocytes (Fig. 1E).
Finally, to exclude the possibility that Nfasc140 is expressed in
neural cells other than neurons, we used primers that span the
second and fourth FNIII repeats that are present in Nfasc186,
Nfasc155, andNfasc140 inRT-PCRof RNApurified fromwhole-
mouse hind brain or optic nerve (Fig. 1B). Postnatal optic nerve
was chosen because it contains a variety of neural cells, including
oligodendrocytes, astrocytes, andmicroglia, but no neuronal cell
bodies, and therefore no neuronal mRNA. The primers were
chosen to discriminate between isoforms where the second
and fourth FNIII repeats are contiguous (Nfasc186 and
Nfasc140) from mRNA where these two domains are sepa-
rated by FNIII3 (Nfasc155) (Fig. 1B). The predicted size of the
products derived from Nfasc186 and Nfasc140 mRNA is iden-
tical (411 bp) and smaller than that from Nfasc155 (732 bp).
Both are readily detectable in hind brain. However, only the
product derived fromNfasc155 was obtained from optic nerve
(Fig. 1F ).
Hence, Nfasc140 is a neuronal neurofascin isoform that is
expressed somewhat earlier than its neuronal counterpart,
Nfasc186. However, although it persists, Nfasc140 is downregu-
lated as myelination proceeds, in contrast to Nfasc186. This sug-
gests that Nfasc140 has a role in the earliest stages of sodium
channel clustering, whereas Nfasc186 has the primary role in
neurons during the period of most active myelination.
Figure 1. Nfasc140 is a neuronal isoform of neurofascin. A, Developmental Western blot of hind brain lysates on two separate gels using a pan anti-neurofascin antibody (NFC) that recognizes
the C terminus of the cytoplasmic domain shows abundant but declining expression of Nfasc140 relative to Nfasc186 in the embryo up until birth (E13-P1), which declines further postnatally at the
onset of myelination (P4–P12) when glial Nfasc155 becomes prominent. Actin was used to ensure equal loading in each group. B, The domain structure of the three neurofascin isoforms.
Sequencing of the Nfasc140 RT-PCR product generated from E15 RNA showed that it lacked the mucin and FNIII5 domains characteristic of neuronal Nfasc186 or the FNIII3 domain unique to
Nfasc155. Ig, Immunoglobulin-like domain; FNIII, fibronectin Type III domain; TM, transmembrane domain. C, Western blots of hind brain lysates at P45 confirmed that Nfasc140 lacked the FNIII3
and mucin/FNIII5 domains found in Nfasc155 and Nfasc186, respectively. As described previously (Tait et al., 2000), the pan anti-neurofascin antibody (NFC) was raised against a region at the
extreme COOH terminus of the intracellular domain common to Nfasc186, Nfasc155, and Nfasc140 (CGNESSEATSPVNAAIYSLA), the second (NFF3) to the third FNIII domain specific to Nfasc155
(CLWVSQKRQQASFPGDRPR), and the third (MNF2) to a sequencewithin themucin domain specific to Nfasc186 (CTESPTTTTGTKIHETAPDEQS). Note the presence of Nfasc155 andNfasc186 bands that
lack the C terminus of the full-lengthproteins. Actinwas the loading control.D, Neuron- andglia-specific Cre-mediated inactivation of theNfascgene shows thatNfasc140 is a neuronal protein.Mice
heterozygous for a floxed allele of Nfasc and heterozygous null for Nfasc and either expressing the transgene encoding a tamoxifen-inducible neuronal Cre (Thy1CreERT2/Nfascfl/) or glial Cre
(PLPCreERT2/Nfascfl/) were treated with tamoxifen at P30, and hind brain lysates were analyzed by Western blot 2.5 months later using the pan anti-neurofascin antibody (NFC). Controls
(Nfascfl/) lacked Cre. Actin was the loading control. E, Neurofascins are not expressed in astrocytes or microglia. Double-label immunofluorescence using the pan anti-neurofascin antibody (NFC)
(green) with either anti-GFAP for astrocytes (red) or anti-IBA1 for microglia (red) reveals neurofascins at axonal nodes and paranodes (arrows) but not in either astrocytes or microglia. Nfasc186 is
not expressed in olgodendrocytes. Double-label immunofluorescence using the Nfasc186-specific antibody (MNF2) (green) and the oligodendrocyte-specific antibody APC shows labeling of axonal
nodes (arrow) but no Nfasc186 in oligodendrocytes (red). Scale bar, 5m. F, Neither Nfasc186 nor Nfasc140 is expressed in non-neuronal cells. RT-PCR was used to discriminate between mRNAs
encoding either Nfasc186 and Nfasc140 (411 bp) or Nfasc155 (732 bp) in total hind brain (HB) RNA or in optic nerve (ON) RNA.
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Nfasc140 is reexpressed in demyelinatedMS lesions
We have previously shown that demyelination in MS lesions
leads to disruption of the nodal and paranodal domains (Howell
et al., 2006). Because Nfasc140 is normally expressed strongly at
the very earliest stages of myelination, we asked whether this
neurofascin isoform might be reexpressed in chronic active le-
sions where demyelination was occurring. Lesions were identi-
fied as described inMaterials andMethods (Fig. 2A). As expected,
Nfasc140 is either not detectable or present at very low levels by
Western blot in mature non-neurological control white matter
(Fig. 2B,C). In contrast, chronic active lesions in four different
MS patients reexpress a smaller form of neurofascin, with a mo-
bility in SDS-PAGE identical to Nfasc140 (Fig. 2B). Although the
levels of Nfasc186 were highly variable (data not shown), expres-
sion of the paranodal glial neurofascin, Nfasc155, persisted, indi-
cating the presence of oligodendrocytes in the lesions (Fig. 2B).
The variations in the relative amounts of Nfasc140 and Nfasc155
(the latter being a marker of oligodendrocytes) presumably re-
flect the fact that the MS patients were of varying age and disease
duration and the fact that the samples were not from anatomi-
cally identical places. Comparison of normal-appearing white
matter with adjacent chronic active lesions in two different sub-
jects confirmed that this lower bandwasmuchmore abundant in
the lesions (Fig. 2C). Domain-specific antibodies supported the
Figure 2. Nfasc140 is reexpressed in demyelinated lesions. Aa, Chronic active lesions (L) were defined by a lack of PLP staining compared with the normal-appearing white matter (N) and, as
shown inAb, a rimof increasednumbers of activatedHLAClass II-positivemicroglia.Ac, Demyelinated axons, as visualized byneurofilament staining, persisted in the lesions, as also shownat higher
magnification in the inset area delineated by the box. Scale bar: 100m; inset, 10m. B, Western blot using the NFC antibody (Pan-Nfasc) described in the legend to Figure 1 of lysates from the
whitematter of four different control subjects (C32, C36, C37, C45) and from chronic active lesions from four different MS patients (MS200, MS203, MS207, MS256) show the presence of Nfasc155,
confirming the presence of oligodendrocytes but also revealing neuronal Nfasc140 expression in the lesions. Actin is the loading control. C, Western blot comparison of normal-appearing white
matter (N) and chronic active lesions (L) from twodifferent subjects using theNFC antibody (Pan-Nfasc) described in the legend to Figure 1 show that Nfasc140 is increased in the lesions. Actin is the
loading control. D, Western blots of chronic active lesion lysates from the MS2000 subject using the NFC antibody (Pan-Nfasc) described in the legend to Figure 1 and the antibody that recognizes
the fourth FNIII domain specific for glial neurofascin (NFF3) confirm that the Nfasc140 band is not a variant of Nfasc155. The lower band at 116 kDa is probably neurofascin produced by ectodomain
cleavage that lacks the C terminus recognized by Pan-Nfasc as shown in Figure 1C.
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view that this lower band was indeed Nfasc140 (Fig. 2D) and not
a variant of Nfasc155 as has been detected in the brains of MS
patients (Pomicter et al., 2013).
Nfasc140 is targeted to the node of Ranvier and axon
initial segment
To study the function of Nfasc140, it was necessary to use a trans-
genic approach because this neurofascin isoform does not possess
any unique domains not also found in Nfasc186 and Nfasc155 that
wouldpermit either thegenerationof isoform-specific antibodies, as
is the case for Nfasc155 and Nfasc186, or an RNAi knockdown ap-
proach (Tait et al., 2000). To investigate the expression of the trans-
genically expressed protein, we attached a C-terminal FLAG-tag.
We generated transgenic lines expressing Nfasc140 with a
C-terminal FLAG-tag, and one founder (T140) was selected in
which FLAG-tagged Nfasc140 was robustly and ubiquitously ex-
pressed in neurons in both the CNS and PNS in similar fashion to
the T186 transgenic line expressing the FLAG-tagged Nfasc186
(T186) we have described previously (Zonta et al., 2011). The
level of expression of transgenically expressed Nfasc140 and
Nfasc186 in the CNS was comparable, and the sizes of the pro-
teins fromWestern blots were as predicted (Fig. 3A).
Because Nfasc140 is a neuronal neurofascin isoform, we spec-
ulated that, like Nfasc186, it might also be targeted to the node of
Ranvier (Tait et al., 2000). Immunofluorescence labeling showed
that FLAG-tagged Nfasc140 was indeed concentrated at nodes
both in the PNS and the CNS in comparable fashion with
Nfasc186 in wild-type (WT) mice (Fig. 3B). We then asked
whether Nfasc140 was, like Nfasc186, also targeted to AISs where
Nfasc186 is known to play a crucial role in stabilizing the complex
of proteins, including voltage-gated sodium channels in the adult
cerebellum (Zonta et al., 2011). Nfasc140 was targeted to the AIS
inNfasc/mice (Fig. 3C). Further, because the absence of neu-
ronal neurofascin during development causes the concomitant
loss of the cell adhesionmoleculeNrCAM(Zonta et al., 2011), we
asked whether Nfasc140 was able, like Nfasc186, to rescue
Figure 3. Transgenically expressed Nfasc140 is targeted to nodes of Ranvier and the axon initial segment in neurons. A, Western blot analysis of spinal cord lysates from transgenic mice at P42
expressing either Nfasc140 or Nfasc186 tagged at their C termini with FLAG on a neurofascin-null background and blottedwith a pan anti-neurofascin antibody (NFC). Actinwas the loading control.
B, Immunostaining of teased quadriceps (PNS) or spinal cord ventral funiculus (CNS) fibers at P45 shows that both transgenic Nfasc140 andNfasc186 are targeted to the node of Ranvier. Transgenic
Nfasc140 is immunostained with an antibody against the FLAG epitope (green), and all neurofascins at the node (Nfasc140 and Nfasc186) and at the paranode (Nfasc155) are stained with an
antibody that recognizes the C terminus of all full-length neurofascins (NFC) (red). Scale bar, 5m. C, Targeting of transgenic Nfasc140 to the AIS of neurofascin-null cerebellar Purkinje cells at P8
is similar to that of Nfasc186. Immunostainingwas for the C terminus of neurofascins (green), FLAG (red), and calbindin (white).D, Nfasc140 can recruit NrCAM to the AIS of cerebellar Purkinje cells
of neurofascin-null mice at P8. Immunostaining was for the NrCAM (green) and calbindin (white). Scale bar, 10m.
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NrCAM expression at the AIS in neurofascin-null mice, which it
did (Fig. 3D) (Zonta et al., 2011).
It has been proposed that the ankyrin binding site (AnkBD) in
the C-terminal domain of the neurofascins assists in the recruit-
ment of ankyrinG to the node of Ranvier (Davis and Bennett,
1994; Lambert et al., 1997). Therefore, we wished to test whether
theAnkBDdomainwas still functionalwhenaFLAGtagwaspresent
at theCterminus.Weused theyeast two-hybrid technique to test the
interaction of the intracellular domain common to Nfasc186,
Nfasc140, and Nfasc155, with or without the presence of the FLAG
epitope (Fig. 4A). The ankyrinG clone comprised amino acids 464–
759, previously isolated using NfascIC as bait (unpublished data),
and the controls were clones encoding regions of ezrin and
syntenin-1 that have previously been shown to be interactors with
the neurofascin C terminus (Koroll et al., 2001; Gunn-Moore et al.,
2006).
The prediction was that the FLAG-tag would not affect inter-
actionwith the ezrin-binding domain because this lies close to the
transmembrane segment, although because syntenin-1 interacts
with the PDZ-binding motif at the extreme C terminus of the
neurofascins, interaction with syntenin-1 would be abolished
(Koroll et al., 2001; Gunn-Moore et al., 2006). As predicted, in-
teraction of the C-terminal domain of tagged neurofascin with
ezrin was unaffected, whereas syntenin-1 no longer bound when
the FLAG tag was at the C terminus (Fig. 4B). However, and
perhaps surprisingly, the FLAG-tag also inhibited interaction of
ankyrin with the AnkBD in this assay (Fig. 4B). Unfortunately, it
was not possible to confirm this interaction by coimmunopre-
cipitation because the presence of the FLAG tag blocked the ac-
tivity of the best antibody for the purpose, namely, the NFC
antibody. Hence, this must remain a tentative conclusion. Nev-
ertheless, it was interesting that the presence of the FLAG does
not prevent targeting of both Nfasc140 and Nfasc186 to the AIS
and nodes, which suggests that a direct interaction between neu-
ronal neurofascins and ankyrinG may not be essential for node
assembly.
Nfasc140 rescues the nodal complex
We then asked whether Nfasc140 FLAG-tagged at its C terminus
could reconstitute the nodal complex in the axons of Nfasc/
mice in vivo in the absence of an intact axoglial adhesion com-
plex. We have used this transgenic rescue approach previously to
show that neuronal Nfasc186 and glial Nfasc155 have comple-
mentary functions in node assembly
(Sherman et al., 2005; Zonta et al., 2008).
We compared Nfasc140 with Nfasc186
because we knew the latter could rescue
the nodal components on a neurofascin-
null background (Sherman et al., 2005;
Zonta et al., 2008). Expression of trans-
genic Nfasc140 on a neurofascin-null
background was fully able to rescue the
nodal complex in both the PNS and CNS
(Fig. 5). Thus, sodium channels ankyrinG
andIV-spectrin were all targeted to CNS
and PNS nodes by Nfasc140 similar to
Nfasc186 (Fig. 5). Furthermore, the fact
that we assessed targeting at P60 suggests
that these nodal components are quite sta-
ble at the node in the presence of
Nfasc140. NrCAM and gliomedin are
PNS-specific nodal components, whereas
brevican is CNS-specific, and all were tar-
geted appropriately (Fig. 5).
The fact that the transgenicmicewere null forNfasc155meant
that they could not have had intact paranodal axoglial junctions
(Sherman et al., 2005; Zonta et al., 2008). This was reflected in the
redistribution of Kv1.1 channels to a paranodal location from
their normal juxtaparanodal domain (Fig. 5). However, this did
not affect the ability of Nfasc140 (or Nfasc186) to recruit nodal
proteins to the complex.
Amelioration of nerve conduction velocity by Nfasc140 rescue
of the PNS node
Nerve conduction velocity measurements on quadriceps nerves
showed that expression of Nfasc140 at PNS nodes restored nerve
conduction velocities to the same degree as Nfasc186 (Fig. 6A)
(41.2  1.6 m/s for WT, 24.1  2.3 for T140/Nfasc/, and
23.0  1.4 for T186/Nfasc/, values are mean  SEM; n  6
mice for each condition; p  0.0001, one-way ANOVA test fol-
lowed by Tukey’s Multiple Comparison Test) (Fig. 6A). Interest-
ingly, it has been previously shown that, when axoglial junctions
are disrupted by the loss of Caspr, conduction velocities in the
PNS are 59% of WT (Bhat et al., 2001). This agrees remarkably
well with the values for nerves in which nodes were rescued by
Nfasc140 (59%) or Nfasc186 (56%), where in both cases paran-
odal axoglial junctions were deranged due to the absence of
Nfasc155 (Fig. 5) (Sherman et al., 2005). Although still not atWT
values, these conduction velocities are a considerable improve-
ment on the 81% reduction in the speed of conduction in the
peripheral nerves of neurofascin-null mice, which die at P7
(Sherman et al., 2005). Consistent with their electrophysiological
deficits, neurofascin-null mice rescued with Nfasc140 or
Nfasc186 performed poorly on the rotarodmotor behavioral test
(Fig. 6B). Nevertheless, it was noteworthy that, even though the
“rescued” mice had significant gait problems, they were other-
wise healthy and survived up to 9 months of age after which they
were killed.
Discussion
Our data provide further evidence for the essential role played by
theNeurofascin gene in the assembly of the node of Ranvier, a key
axonal domain in myelinated nerves. Hence, three isoforms of
the same protein expressed in two distinct cell types cooperate to
achieve the goal of clustering a macromolecular axonal complex,
namely, voltage-gated sodium channels and its associated pro-
Figure4. Introduction of the FLAG tag at the C terminus of Nfasc186 orNfasc140prevents interactionwith ankyrinG.A, The 109
amino acid cytoplasmic tail common to Nfasc186, Nfasc140, and Nfasc155 (NfascIC) containing AnkBD (Zhang et al., 1998) was
used as bait in a yeast two-hybrid interaction with empty vector (pAS2-1) or clones encoding regions of ezrin, ankyrinG, and
syntenin-1 that had previously been identified as interactors (Davis and Bennett, 1994; Koroll et al., 2001; Gunn-Moore et al.,
2006). B, The degree of interaction was scored (,,,). NfascICFlag was no longer capable of interacting with
ankyrinG.
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teins. This represents an unusual example
of functionally cooperative, cell-type-
specific alternative splicing of a single
gene in cell biology. In the case of the neu-
rofascins, this cooperativity results in the
assembly of an essential structure in the
development of the vertebrate nervous
system.
Further, when considering the func-
tion of the rescued mice, we have previ-
ously found that neurofascin-null mice
rescued with Nfasc186 survive into adult-
hood (Zonta et al., 2011). We also found
that the same was true for mice rescued
with the Nfasc140 transgene. This is quite
surprising given the fact that both types of
mice lack intact paranodal axoglial junc-
tions. This may be due to the fact that the
heterologous promoter used to drive ex-
pression of the Nfasc transgenes, namely,
Thy1.2, remains active throughout adult
life. In contrast, the endogenous neuronal
Nfasc promoter is probably downregulated
in adulthood due to the fact that Nfasc186,
at least, is a very stable protein, which turns
over very slowly at the node of Ranvier
(Zonta et al., 2011).
The Neurofascin gene encodes six Ig repeats, five FNIII re-
peats, and a mucin domain (Davis et al., 1996) (Fig. 1). All three
major neurofascin isoforms have the six Ig repeats; however,
Nfasc186 has FNIII-1, 2, 4, and 5 repeats and the mucin domain,
whereasNfasc155 lacks themucin domain and has the FNIII-1, 2, 3,
and4repeats.Therefore, themucinandFNIII-5domainsareunique
to neuronal Nfasc186, whereas the FNIII-3 domain is unique to
glial Nfasc155. In contrast, Nfasc140 has the FNIII-1, 2, and 4
repeats found in Nfasc186 but lacks FMIII-5 and the mucin do-
main. The fact that Nfasc140 lacks these domains shows that they
are neither required for targeting of Nfasc140 to the node nor are
they necessary for sodium channel clustering. It remains to be
determined what the function of these domains might be. Other
work has shown that Ig5–6 are also dispensable for Nfasc186
targeting to the node (Thaxton et al., 2010), although the ectodo-
main of Nfasc186 is necessary for targeting to the PNS node
Figure 5. Nfasc140 rescues the PNS and CNS nodal complexes as efficiently as Nfasc186 in Nfasc/mice. Immunostaining of teased quadriceps (PNS) and spinal cord ventral funiculus fibers
(CNS) at P60 shows that both FLAG-tagged Nfasc140 and Nfasc186 can rescue the nodal components, voltage-gated sodium channels (Nav), ankyrinG, and IV-spectrin when expressed on a
neurofascin-null background. Additionally, the PNS-specific nodal proteins NrCAM and gliomedin were also rescued, as was the CNS-specific nodal protein brevican. Rescue of the node was not
accompanied by reformation of the axoglial junction; and, as a consequence, juxtaparanodal Kv1.1 channels were mislocalized compared with WT. Scale bars, 5m.
Figure6. Nfasc140 restores limited nodal function in 2-month-oldNfasc/mice.A, Conduction velocitiesweremeasured in
quadriceps nerves from mice at P60. Although significantly less than WT mice, values from mice expressing Nfasc140 were not
significantly different from those expressing Nfasc186. B, T140/Nfasc/ and T186/Nfasc/ P60 animals were significantly
worse thanWTmice on the rotarod. And the deficit comparing the twodifferent transgenic animalswas not significantly different.
Data aremean SEM; n 6mice for electrophysiology and n 4 for rotarod. ***p 0.0001 (one-way ANOVA test followed by
Tukey’s Multiple Comparison Test).
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(Dzhashiashvili et al., 2007). Further, although there is evidence
that ankyrinGpromotes sodiumchannel clustering at the PNSnode
(Dzhashiashvili et al., 2007), our data show that interaction of anky-
rinG with either Nfasc186 or Nfasc140 is not necessary for either
targetingormaintenanceof sodiumchannels at thenode inboth the
CNS and PNS.
Nfasc140 appears to have a similar structure and developmen-
tal pattern of expression to NF166, previously described in chick
(Pruss et al., 2006). The early expression of Nfasc140 during de-
velopment suggests that Nfasc140 complements the function of
Nfasc155 and Nfasc186 in the initial stages of the assembly and
stabilization of the nodal complex. Further, Nfasc140 is reex-
pressed in demyelinated regions of postmortembrain tissue from
human subjects with MS. Our previous studies demonstrated
that Nfasc186 expression was disrupted in MS white matter le-
sions and became diffusely distributed along demyelinated axons
in amanner similar to sodium channels (Howell et al., 2006). The
demonstration that Nfasc140, which is normally absent from
adult axons, becomes reexpressed in demyelinated lesions sug-
gests a return to a premyelinating state, perhaps in preparation
for remyelination to occur. This is in keeping with the reduced
expression of Nfasc155 in the same demyelinated lesions, indi-
cating the presence of some oligodendrocytes or residual myelin.
In conclusion, this work expands the critical role of the Nfasc
gene in the function of myelinated axons and reveals further
redundancy in themechanisms required for the formation of this
crucial structure in the vertebrate nervous system.
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